Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6085 (MIR6085) is a short, non-coding RNA molecule (20–24 nucleotides) that belongs to the large family of microRNAs. These molecules are transcribed as longer primary transcripts, processed in the nucleus and cytoplasm by Drosha and Dicer enzymes, and loaded onto the RNA-induced silencing complex (RISC). Mature miRNAs pair with partially complementary sequences within target mRNAs, resulting primarily in translational repression or destabilization of those mRNAs. MIR6085's specific biological roles are not well-characterized, but the general function of microRNAs encompasses critical regulation of gene expression in numerous cell and developmental processes, with broad involvement in disease mechanisms wherever gene regulation is disrupted. MIR6085 has been associated with Ebstein anomaly, but its mechanistic role in this or other conditions has not yet been established in the literature.
RISC-mediated repression of target mRNAs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6085 (MIR6085).